184 related articles for article (PubMed ID: 33261651)
1. Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.
Florczak A; Deptuch T; Lewandowska A; Penderecka K; Kramer E; Marszalek A; Mackiewicz A; Dams-Kozlowska H
J Nanobiotechnology; 2020 Dec; 18(1):177. PubMed ID: 33261651
[TBL] [Abstract][Full Text] [Related]
2. Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells.
Kucharczyk K; Florczak A; Deptuch T; Penderecka K; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
J Nanobiotechnology; 2020 Mar; 18(1):56. PubMed ID: 32228620
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.
Florczak A; Mackiewicz A; Dams-Kozlowska H
Int J Nanomedicine; 2019; 14():6855-6865. PubMed ID: 32021156
[TBL] [Abstract][Full Text] [Related]
4. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
Florczak A; Mackiewicz A; Dams-Kozlowska H
Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
[TBL] [Abstract][Full Text] [Related]
5. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.
Florczak A; Jastrzebska K; Bialas W; Mackiewicz A; Dams-Kozlowska H
J Biomed Mater Res A; 2018 Dec; 106(12):3211-3221. PubMed ID: 30242958
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
[TBL] [Abstract][Full Text] [Related]
7. In vivo study of the immune response to bioengineered spider silk spheres.
Deptuch T; Penderecka K; Kaczmarek M; Molenda S; Dams-Kozlowska H
Sci Rep; 2022 Aug; 12(1):13480. PubMed ID: 35931709
[TBL] [Abstract][Full Text] [Related]
8. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
10. Bioengineering the spider silk sequence to modify its affinity for drugs.
Kucharczyk K; Weiss M; Jastrzebska K; Luczak M; Ptak A; Kozak M; Mackiewicz A; Dams-Kozlowska H
Int J Nanomedicine; 2018; 13():4247-4261. PubMed ID: 30050299
[TBL] [Abstract][Full Text] [Related]
11. pH-dependent anticancer drug release from silk nanoparticles.
Seib FP; Jones GT; Rnjak-Kovacina J; Lin Y; Kaplan DL
Adv Healthc Mater; 2013 Dec; 2(12):1606-11. PubMed ID: 23625825
[TBL] [Abstract][Full Text] [Related]
12. MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.
Kucharczyk K; Florczak A; Kaminska A; Guzniczak N; Sikorska A; Deptuch T; Dams-Kozlowska H
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132016. PubMed ID: 38697442
[TBL] [Abstract][Full Text] [Related]
13. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
15. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
[TBL] [Abstract][Full Text] [Related]
16. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
Kefayat A; Vaezifar S
Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [Abstract][Full Text] [Related]
19. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
